Cargando…

Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study

OBJECTIVES: This study examines financial conflict of interest (FCOI) of clinicians who made submissions to the pan-Canadian Oncology Drug Review (pCODR), the arm of the Canadian Agency for Drugs and Technology in Health that recommends whether oncology drug indications should be publicly funded. Fi...

Descripción completa

Detalles Bibliográficos
Autor principal:	Lexchin, Joel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Health Policy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661552/ https://www.ncbi.nlm.nih.gov/pubmed/31350254 http://dx.doi.org/10.1136/bmjopen-2019-030750

Ejemplares similares

Drug approval status and recommendations for listing on public formularies: a Canadian cohort analysis
por: Lexchin, Joel
Publicado: (2017)

A cross-sectional study of all clinicians’ conflict of interest disclosures to NHS hospital employers in England 2015-2016
por: Feldman, Harriet Ruth, et al.
Publicado: (2018)

Financial conflicts of interest among US physician authors of 2020 clinical practice guidelines: a cross-sectional study
por: Mooghali, Maryam, et al.
Publicado: (2023)

Comparison of drug coverage in Canada before and after the establishment of the pan-Canadian Pharmaceutical Alliance
por: Milliken, Debbie, et al.
Publicado: (2015)

Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase
por: Shnier, Adrienne, et al.
Publicado: (2016)

Time to market for drugs approved in Canada between 2014 and 2018: an observational study
por: Lexchin, Joel
Publicado: (2021)

Postmarket safety in Canada: are significant therapeutic advances and biologics less safe than other drugs? A cohort study
por: Lexchin, Joel
Publicado: (2014)

Quality of evidence considered by Health Canada in granting full market authorisation to new drugs with a conditional approval: a retrospective cohort study
por: Lexchin, Joel
Publicado: (2018)

Too Few, Too Weak: Conflict of Interest Policies at Canadian Medical Schools
por: Shnier, Adrienne, et al.
Publicado: (2013)

Institutional financial conflicts of interest policies at Canadian academic health science centres: a national survey
por: Rochon, Paula A, et al.
Publicado: (2010)

Submission policy, peer-review and editorial board members: interesting conflicts and conflicts of interest
por: Søreide, Kjetil, et al.
Publicado: (2010)

Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study
por: Diep, Dion, et al.
Publicado: (2020)

Investigator experiences with financial conflicts of interest in clinical trials
por: Rochon, Paula A, et al.
Publicado: (2011)

A qualitative study of manufacturers' submissions to the UK NICE single technology appraisal process
por: Kaltenthaler, Eva C, et al.
Publicado: (2012)

How are clinical commissioning groups managing conflicts of interest under primary care co-commissioning in England? A qualitative analysis
por: Moran, Valerie, et al.
Publicado: (2017)

National patient groups in Canada and their disclosure of relationships with pharmaceutical companies: a cross-sectional study
por: Lexchin, Joel, et al.
Publicado: (2022)

Financial Conflicts of Interest Checklist 2010 for clinical research studies
por: Rochon, Paula A, et al.
Publicado: (2010)

How long do new medicines take to reach Canadian patients after companies file a submission: A cohort study
por: Lexchin, Joel
Publicado: (2020)

Inpatient clinician workload: a scoping review protocol to understand the definition, measurement and impact of non-procedural clinician workloads
por: Smith, Erica Mitchell, et al.
Publicado: (2022)

Global Health Philanthropy and Institutional Relationships: How Should Conflicts of Interest Be Addressed?
por: Stuckler, David, et al.
Publicado: (2011)

How are declarations of interest working? A cross-sectional study in declarations of interest in healthcare practice in Scotland and England in 2020/2021
por: McCartney, Margaret, et al.
Publicado: (2022)

New drug submissions in Canada and a comparison with the Food and Drug Administration and the European Medicines Agency: Cross-sectional analysis
por: Lexchin, Joel
Publicado: (2023)

What Should We Concern in Reporting Conflict of Interest for Submission of Manuscript in the Psychiatry Investigation?
por: Hwang, Jun-Won
Publicado: (2018)

Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009
por: Benea, Carla, et al.
Publicado: (2020)

Mixed methods evaluation of workshops for citizen health advocates about financial conflicts of interests in healthcare
por: Moynihan, Ray, et al.
Publicado: (2020)

Financial Conflicts of Interest Among the Authors of the Clinical Practice Guidelines for Rheumatoid Arthritis in Japan
por: Murayama, Anju
Publicado: (2023)

Financial Toxicity in Head and Neck Cancer Patients Treated With Proton Therapy
por: Smith, Grace L., et al.
Publicado: (2021)

Is It Possible to Solve the Conflicts Over Conflict of Interest? Comment on "Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool"
por: Bialous, Stella Aguinaga
Publicado: (2021)

RELATIONSHIP BETWEEN FINANCIAL IMPACT AND COVERAGE OF DRUGS IN AUSTRALIA
por: Mauskopf, Josephine, et al.
Publicado: (2013)

Perceptions and experiences of financial incentives: a qualitative study of dialysis care in England
por: Abma, Inger, et al.
Publicado: (2014)

Understanding patient partnership in health systems: lessons from the Canadian patient partner survey
por: Abelson, Julia, et al.
Publicado: (2022)

Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study
por: Turner, Kimberly, et al.
Publicado: (2020)

Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study
por: Roseman, Michelle, et al.
Publicado: (2012)

The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States
por: Gagnon, Marc-André, et al.
Publicado: (2008)

Impact of Medicare prescription drug (Part D) coverage expansion on utilisation and financial burden of benzodiazepines among older adults: an interrupted time series analysis
por: Li, Minghui, et al.
Publicado: (2021)

The Repurposing Drugs in Oncology (ReDO) Project
por: Pantziarka, Pan, et al.
Publicado: (2014)

Divergent modes of integration: the Canadian way
por: Jiwani, Izzat, et al.
Publicado: (2011)

Conflict of Interest in Nutrition: Where’s the Power? Comment on "Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool"
por: Harris, Jody, et al.
Publicado: (2020)

Association of off-the-job training with work performance and work–family conflict among physicians: a cross-sectional study in China
por: Wang, Xiaoyu, et al.
Publicado: (2022)

Access to healthcare and financial risk protection for older adults in Mexico: secondary data analysis of a national survey
por: Doubova, Svetlana V, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tfoqr5lvo2om1g19ftg7uv1e93